UNSPSC 51241866: Fluocinolone/hydroquinone/tretinoin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE900. This VA Drug Class (DE900) classifies this compound as belonging to the group DERMATOLOGICALS, TOPICAL OTHER.

UNSPSC 51241866 Fluocinolone/hydroquinone/tretinoin is a Commodity code that encompasses specialized pharmaceutical topical formulations. However, recent state and local procurement activity under this code does not reflect its nominal scope. The City of Tampa Fire Rescue Department's ITB 25-P-00157, posted April 24, 2026, nominally tagged under this code, solicits general medical aid supplies including antiseptic sprays, hydrogen peroxide, aspirin, pain relievers, bandages, first aid kits, and emergency blankets—products unrelated to the dermatological compounds the code describes. The mismatch between the code assignment and the actual procurement suggests either miscoding or a broad-interpretation application of the taxonomy that does not reflect typical usage. The $100,000 total budget and the one-year initial award period with two optional renewals indicate a routine municipal supply replenishment rather than a specialized pharmaceutical procurement.

The Tampa solicitation represents the only recent state and local opportunity identified under this code, with response due April 9, 2025. The City of Tampa is the issuing body, and the procurement includes set-aside provisions for City-certified Small Local Business Enterprises (SLBEs) and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs), offering up to a 5% bid discount on the total bid amount, not to exceed $10,000 for SLBEs and $20,000 for U-WMBEs. Given the sparse and misaligned activity observed, this code shows little relevant recent state and local purchasing momentum. Firms pursuing procurement under the dermatological-compound interpretation of this code should monitor for future solicitations in dermatology supply chains, which remain absent from current visible activity.